3-Hydroxyphencyclidine (3-HPC), a metabolite of phencyclidine (PCP), is increasingly attracting scientific scrutiny due to initial evidence suggesting distinct biological properties. Current studies demonstrate that 3-HPC may exhibit separate impacts on the nervous system, arguably contributing to some of the unexpected symptoms associated with PCP